Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 308

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Nuclear Receptor Minireview Series

Open access
Olefsky, Jerrold M. · 2001 · Journal of Biological Chemistry

Abstract

nuclear hormone receptor DNA binding domain ligand binding domain estrogen receptor estrogen response element peroxisome proliferator-activated receptor thiazoladinedione The nuclear receptor superfamily describes a related but diverse array of transcription factors, which include nuclear hormone receptors (NHRs)1 and orphan nuclear receptors. NHRs are receptors for which hormonal ligands have been identified, whereas orphan receptors are so named because their ligands are unknown, at least at the time the receptor is identified. Unlike hormones for cell surface receptors, lipophilic hormones can traverse the plasma membrane to the cell interiors where NHRs transduce signals from glucocorticoids, mineralocorticoids, the sex steroids (estrogen, progesterone, and androgen), thyroid hormones, and vitamin D3. All of the nuclear receptors have common structural features (Fig.1), which include a central DNA binding domain (DBD) responsible for targeting the receptor to highly specific DNA sequences comprising a response element (1Bourguet W. Germain P. Gronemeyer H. Trends Pharmacol. Sci. 2000; 21: 381-388Abstract Full Text Full Text PDF PubMed Scopus (380) Google Scholar). The ligand binding domain (LBD) is contained in the C-terminal half of the receptor and recognizes specific hormonal and nonhormonal ligands directing specificity to the biologic response. These receptors contain variable N-terminal and C-terminal domains, as well as a variable length hinge region between the DBD and LBD. Nuclear receptors can exist as homo- or heterodimers with each partner binding to specific RE sequences that exist as half-sites separated by variable length nucleotide spacers between direct or inverted half-site repeats. Several years ago Manglesdorf et al. (2Mangelsdorf D.J. Thummel C. Beato M. Herrlich P. Schültz G. Umesono K. Blumberg B. Kastner P. Mark M. Chambon P. Evans R.M. Cell. 1995; 83: 835-839Abstract Full Text PDF PubMed Scopus (6002) Google Scholar) proposed four categories of nuclear receptors in which Class 1 receptors include the known steroid hormone receptors, which function as homodimers binding to half-site RE inverted repeats. Class 2 receptors exist as heterodimers with RXR receptor partners and function in a ligand-dependent manner. The second two classes include orphan receptors, which function as homodimers binding to direct RE repeats (Class 3) or monomers binding to single site REs (Class 4). Given the widespread relevance of the superfamily of nuclear receptors to almost all aspects of normal human physiology, the role of these receptors in the etiology of many human diseases, and their importance as therapeutic targets for pharmaceuticals, it is obvious that a detailed understanding of these systems has major implications, not only for human biology but also for the understanding and development of new drug treatments. In composing this minireview series, it is quite clear that it is not feasible to comprehensively review any of the separate areas in great detail, and all of the minireviews in this series contain references to more extensive review papers on particular topics. As in all minireviews, the purpose of this series is to highlight major themes and new developments in these areas and to point out common molecular and biochemical principles that broaden our understanding of these complex biological processes. The first article in the series is entitled “Coregulator Codes of Transcriptional Regulation by Nuclear Receptors” authored by Michael G. Rosenfeld and Christopher K. Glass. This review covers the complex and ever-growing network of interactions between coregulatory proteins and nuclear receptors. These regulatory proteins form multicomponent assemblies with the nuclear receptors, and these complexes can serve as coactivators or corepressors. The specific proteins in these complexes can bind to nuclear receptors via specific amino acid sequence motifs in a ligand-dependent or independent manner and can provide enzymatic or scaffolding functions. These coregulators influence chromatin remodeling by histone acetylation/deacetylation, methylation, and possibly other events. In general, ligand binding to nuclear receptors causes an exchange of coactivators for corepressors to facilitate transcription. This review also points out that the coregulatory proteins themselves are subject to biochemical and functional regulation by various signaling pathways. Far more coregulatory molecules have been identified than can bind to a given nuclear receptor, and given recent findings of rapid turnover of these complexes on DNA, it is possible that they work in a combinatorial or sequential manner to exert transcriptional control. Given the tissue specificity of some coregulators, their ability to be modified by various other signaling molecules, and possible combinatorial functions, one can envision that a given nuclear receptor could exert diverse effects depending on the environmental context o

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.r100047200

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 308

Metadata

Authors
Olefsky, J. M.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2001-10
Volume
276
Issue
40
Pages
36863-36864
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2031906658
Cited by
308
References
2
FWCI
6.38
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nuclear Receptor Minireview Series. https://app.cochat.ai/papers/10.1074/jbc.r100047200
The paper
Olefsky, J. M. (2001). Nuclear Receptor Minireview Series. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.r100047200

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.